Abstract: Elastin-Like Polypeptides (ELPs) reversibly phase separate in response to changes in temperature, pressure, concentration, pH, and ionic species. While powerful triggers, biological microenvironments present a multitude of more specific biological cues, such as antibodies, cytokines, and cell-surface receptors. To develop better biosensors and bioresponsive drug carriers, rational strategies are required to sense and respond to these target proteins. We recently reported that noncovalent association of two ELP fusion proteins to a "chemical inducer of dimerization" small molecule (1.5 kDa) induces phase separation at physiological temperatures. Having detected a small molecule, here we present the first evidence that ELP multimerization can also detect a much larger (60 kDa) protein target. To demonstrate this strategy, ELPs were biotinylated at their amino terminus and mixed with tetrameric streptavidin. At a stoichiometric ratio of [4:1], two to three biotin-ELPs associate with streptavidin into multimeric complexes with an apparent K d of 5 nM. The increased ELP density around a streptavidin core strongly promotes isothermal phase separation, which was tuned to occur at physiological temperature. This phase separation reverses upon saturation with excess streptavidin, which only favors [1:1] complexes. Together, these findings suggest that ELP association with multimeric biomolecules is a viable strategy to deliberately engineer ELPs that respond to multimeric protein substrates.
Introduction
Protein-polymers are recombinant polypeptides that can be genetically engineered, which allows precise control over their composition and biosynthesis. One class of protein-polymers are the elastin-like polypeptides (ELPs), which are biologically inspired from human tropoelastin. 1 Typical ELPs are composed of repetitive pentameric sequence (Val-Pro-Gly-XaaAdditional Supporting Information may be found in the online version of this article.
Supporting Information: Consists of genes encoding for the Elastin-like polypeptide library with increasing chain length and unmodified control ELP unable to detect and respond to streptavidin.
Broader Significance: ELPs are environmentally responsive polypeptides that phase separate as a function of well-established variables including temperature, concentration, and molecular weight. What remains unclear is how to rationally design ELPs that phase separate in response to specific biological substrates, such as proteins. Here, we report that a high molecular weight multimeric protein can associate with multiple ELPs; furthermore, this complexation triggers phase separation. While others have described switchable ELPs, to the best of our knowledge we are the first group to rationally design ELPs to phase separate upon binding of a high molecular weight multimeric protein.
Gly) l where Xaa is a guest residue and l defines the molecular weight. ELPs are highly water soluble until they are heated beyond their inverse phase transition temperature, T t . Above T t , ELPs phase separate from bulk water, a process that can be tuned by changing ELP concentration and molecular weight. 2, 3 Since ELPs can be fused to different functional domains such as cell trafficking proteins, 4 drug-binding receptors 5, 6 and antibody fragments, 7 this enables them to bind and recognize different targets. By combining the ELP-mediated phase separation and the ability of fused domains to bind specific targets, ELP fusions and bioconjugates make an excellent platform for developing smart bioresponsive polymers. The rationale of this work is that ELP phase separation depends on molecular weight, concentration, and local hydrophobicity; therefore, target biomolecules that shift these properties may induce isothermal phase separation at physiological temperature. If successful, this design strategy may enable development of ELP fusions that both detect and deliver agents to diseased microenvironments with high selectivity. We recently reported that noncovalent dimerization of two FKBP-ELP fusion proteins (32, 41 kDa) induces ELP phase separation upon binding to a small molecule target (1.5 kDa) called a "chemical inducer of dimerization". 8 This manuscript takes this design strategy to the next logical step, to detect a high molecular weight multimeric protein, streptavidin ( Fig. 1) . Although previous studies have described ELPs that respond to an allosteric ligand 9 or use phase separation of synthetic polymers to modulate protein-ligand interactions, [10] [11] [12] [13] we are the first group to report that noncovalent ELP crosslinking is a simple design strategy to detect multimeric biomolecules. In this manuscript, we extend our hypothesis and report that: (i) ELP phase separation can also detect large (60 kDa) tetrameric proteins; and (ii) this can be tuned to occur at physiological temperatures even with a high molecular weight ELP (77 kDa) (Table I) . Due to the ubiquity of multimeric proteins in nature, including IL-5 cytokine (dimer), 14 hemoglobin (tetramer), 15 immunoglobulins of class IgA (dimer) 16 and IgM (pentamer), 17 and cell-surface receptor tyrosine kinases (dimer) like VEGFR and EGFR, [18] [19] [20] crosslinking ELPs might be designed to detect many species important in diagnostic and therapeutic applications. Streptavidin is a 60 kDa homotetrameric protein isolated from S.avidinii. 21 Each subunit of streptavidin has a potential biotin binding pocket.
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Given many possible proteins with multimeric quaternary structures, we chose streptavidin to study ELP multimerization because: (i) biotin-streptavidin interactions are well-characterized with picomolar affinity, 23 which may provide a strong association between biotin-ELPs and streptavidin; (ii) biotin is a small molecule that can be bioconjugated at high yield and specificity to the amino terminus of purified ELPs; (iii) surprisingly, no other investigators have reported a relationship between streptavidinbiotin interactions and the ELP phase behavior. Although streptavidin-ELP interactions have been recently explored to enhance an immunoassay, 24 to the best of our knowledge, this is the first report that ELP assembly on streptavidin significantly changes ELP phase behavior. Future iterations of Figure 1 . Designing bioresponsive ELPs that phase separate in response to a model multimeric protein: streptavidin. BiotinELPs phase separate above a relatively high temperature and remain soluble; however, when they crosslink with streptavidin, the resulting complex undergoes rapid phase separation. This concept provides a rational strategy to design switchable ELPs that detect multimeric proteins at a constant physiological temperature.
this design strategy may be useful to develop bioresponsive diagnostics and therapeutics that bind to other multimeric species.
Results

Purification of biotin-ELP and characterization of its phase behavior
To test the hypothesis that ELP multimerization can drive isothermal assembly near a physiologicallyrelevant temperature, a new 77 kDa high molecular weight ELP, 2VA192, was constructed with amino acid sequence MG(VPGVGVPGVGVPGAG) 64 Y. 2VA192 was purified from E. coli with yields of 30-50 mgs/L. The identity and purity (94%) was determined using SDS-PAGE gel [ Fig. 2(A) ]. This particular ELP was chosen because its molecular weight is greater than the 60 kDa streptavidin tetramer; furthermore, its repetitive sequence containing valine and alanine in a 2:1 ratio enables it to phase separate near physiological temperatures within target concentrations between 1 and 10 lM ( Table I ). The concentration-temperature phase diagram for the entire (2VA) ELP library with increasing chain length (Supporting Information Table SI) was determined by measuring optical density as a function of temperature [ Fig. 2(B) ]. Similarly, the T t of biotin-ELP with and without stoichiometric ratio of streptavidin [4:1] was determined [ Fig. 2(C) ]. As observed, biotinylation of 2VA192 had little influence on T t ; however, when biotin-ELP was combined with streptavidin, both the magnitude and slope of line decreased. To quantify this shift in phase behavior, each individual ELP in this library was fit by the following equation:
The intercept, b, is the T t at a reference concentration of 1 lM. The slope, m, can be interpreted as the decrease in T t with a ten-fold increase in concentration, C ELP . Using Eq. (1), the working T t of each ELP can be estimated at any concentration (Table I ). For example, 1 lM biotin-ELP is soluble at physiological temperature (T t , intercept 388C); however, if concentrated to 10 lM, it would phase separate at body temperature (T t 348C) [ Fig. 2(C) ]. Usefully, this fit reveals that the slope, m, of the temperatureconcentration phase diagram for biotin-ELP drops from 3.8 to 2.08C upon binding with streptavidin (Table I) . To further interpret this change to the phase diagram, the phase behavior for the entire library [ Fig. 2(B) ] was next fit to a previously described model 2 using:
where best-fit parameters T c 5 22.7 6 2.48C, k 5 337 6 468C pentamers, and C c 5 5214 6 3878 lM describe the transition temperature for any length, l in pentamers, or concentration of ELPs with the amino acid composition in Table I . Insertion of these parameter values into Eq. (2) and rearranging yields:
Based on inspection of Eqs.
(1) and (3), the apparent number of ELP pentamers needed to complex with streptavidin to result in slope, m, can be estimated as follows:
Using the 95% confidence interval [1.6 to 2.48C] (Table I) , for the slope of the biotin-ELP: streptavidin complex, Eq. (4) may be used to estimate that a multimeric complex containing between l 5 323 and 485 ELP pentameric repeats might be expected to have slope similar to that observed. Since each biotin-ELP is composed from 192 repeats, an average complex containing between 1.7 and 2.5 biotinELPs per streptavidin would be consistent with the phase behavior observed [ Fig. 2(C) ].
Biotin-ELP associate into dimeric and trimeric complexes with streptavidin
Having observed that complexation between biotinELPs and streptavidin yields a quantifiable shift in kJ/mol and (iv) Gibbs free energy (DG) of 247.5 6 1.4 kJ/mol. Based on overall negative DG, which is the sum of enthalpy and entropy, interactions between about three biotin-ELPs and streptavidin appear to be thermodynamically favorable.
Fine tuning biotin-ELP detection of streptavidin to occur at physiological temperatures
After demonstrating that a molar ratio of biotin-ELP to streptavidin [4:1] results in assembly of dimeric and trimeric ELP complexes with reduced phase transition temperatures, these complexes were further tuned such that their assembly occurs at physiologically relevant temperatures. First, a 5 lM biotin-ELP solution in PBS was heated with and without streptavidin and the T t was identified. Binding of streptavidin to biotin-ELP lowered the phase transition temperature by 38C compared to the control [ Fig. 4(A,B) ]. Having determined the T t with and without streptavidin, the kinetics of coacervation . S1 ).
To tune the phase separation to occur around 378C, this experiment was repeated using 1 lM biotin-ELP, which produced an 48C decrease in T t upon adding streptavidin [ Fig. 4(D, E) ]. Upon addition of the stoichiometric ratio of streptavidin, the system again rapidly phase separated due to ELP multimerization [ Fig.  4(F) ]. Both experiments demonstrate how simple it is to tune and detect target concentrations of streptavidin near physiologically relevant temperatures.
Biotin-ELP transition temperature responds to multimerization at different streptavidin ratios
While it was clear that streptavidin reduces T t for biotin-ELP, it remained unclear what degree of multimerization (dimer, trimer) dominated this shift or how the ratio between biotin and streptavidin affects phase separation. To further explore these questions, biotin-ELP at a fixed concentration was incubated with streptavidin below and above After demonstrating that the biotin-ELP T t responds in a biphasic manner to streptavidin concentration, the relative size of these complexes was then probed using dynamic light scattering (DLS) over similar ratios below and above stoichiometry [ Fig. 5(E) ]. To avoid the scattering of light by coacervate particles and to interpret the size of the crosslinked complex in its soluble state, particle size was measured at 258C, a temperature well below the T t for biotin-ELP complexes [ Fig. 2(C) ]. To detect sufficient scattering from both free streptavidin and biotin-ELP, a 4-fold higher concentration of biotin- ELP (20 lM) was required. Similar to the biphasic response in T t , biotin-ELP streptavidin complexes also displayed a biphasic change in particle size distribution (Table II) . Under these conditions, free streptavidin displayed a hydrodynamic radius, R h of 4.7 6 0.7 nm and free biotin-ELP displayed a R h , of 7.3 6 0.4 nm. When biotin-ELPs were mixed with different ratios of streptavidin, the R h of the crosslinking complexes were 10. , which permits the maximum concentration of ELP multimers. Subsequent increase in streptavidin concentration competes apart multimers, returning T t back upwards (n 5 3, mean 6 SD). (D) As a control, 5 mM unlabeled ELP (2VA192) was incubated with different streptavidin concentrations below and above stoichiometry. No change in T t was observed which confirms that streptavidin has no effect on unmodified ELP (E) Dynamic light scattering was used to compare the particle size distributions at 258C for free streptavidin, free biotin-ELP and biotin-ELP: streptavidin mixed in ratios of 16:1, 4:1, and 1:1 (Table  II) . A near stoichiometric [4:1] mixture of biotin-ELP produces the largest hydrodynamic radius, consistent with the assembly of multimeric complex. A representative data set from n 5 3 is shown.
Discussion
Polymer phase separation has been previously explored for various biosensing applications. Synthetic polymers like poly(N-isopropylacrylamide), 10 poly(N,N-diethylacrylamide) 11 and N-4-phenylazophenylacrylamide 12 have been reported to respond to stimuli, such as temperature and light, to control binding of small molecules to target proteins. In comparison to synthetic polymers, protein-polymers may have added advantages as smart polymers due to recombinant production that enables their precise linkage with functional proteins. For example, the ELP protein-polymers are produced using cellular translation machinery, which promotes control over their design, arrangement, and reproducibility and can eliminate the need for chemical bioconjugation. 25 ELPs fused with calmodulin have been reported to undergo phase separation in response to binding of Ca 21 , which was reversed by chelation of Ca 21 by EDTA. 9 An alternative design strategy developed smart ELPs with negatively charged calcium-binding motifs to respond upon neutralization by divalent Ca 21 cations. 26 Despite these innovative biosensing applications, no approaches have defined a strategy based on ELP multimerization as a workable strategy to respond to target proteins. To address this untapped niche, our group first demonstrated that ELP dimerization is a viable technique to detect small ligand molecules. In this manuscript, we extend this defined multimerization strategy from the detection of a small molecule to a large multimeric protein.
It has been known that various environmental parameters can induce ELP-mediated phase separation 27, 28 ; however, few reports have discussed how interactions with other macromolecules affect assembly. The primary finding of this manuscript is that biotin-ELPs change their phase behavior upon binding their target protein; furthermore, this is mediated through assembly of multimeric structures. Our working model is that ELPs in the presence of a stoichiometric amount of a target protein assemble multivalent complexes [Figs. 2, 4 , 5], which increases the local density of ELPs and reduces the observed T t . When the T t of biotin-ELP was studied across increasing streptavidin concentrations, a distinct biphasic ligand-binding trend was observed [ Fig. 5(C) ]. This relationship was further explored by extrapolating the data in [ Fig. 2(B) ] using Eq. (2) with an assumption that biotin-ELPs complexed around a streptavidin core would behave similarly to ELPs with greater length. This assumption allows estimation of the number of ELP pentamer repeats, l, necessary to achieve the same phase diagram observed for biotin-ELP in the presence of [4:1] streptavidin [ Fig. 2(C) , Table I ]. This extrapolation estimates that between 1.7 to 2.5 biotin-ELPs are bound to the average streptavidin. This assumption was then independently validated using ITC, whereby a remarkably similar biotin-ELP/streptavidin binding stoichiometry of 2.77 6 0.06 was obtained. Taken together, these findings suggest that ELP multimerization is sufficient to detect mixtures of dimeric and trimeric ELP complexes. This strategy will be the most useful if it can generate fusion proteins that respond to target biomolecules at physiological concentrations and constant temperatures. Therefore, we used this approach to show how simple it is to design ELPs to detect streptavidin at a constant temperature relevant to physiology [ Fig. 4 ]. When streptavidin was added to 5 mM biotin-ELP at 33.58C, the sharp rise in optical density confirmed that ELP can successfully detect streptavidin by rapid phase separation, which could be tuned to physiological temperature by lowering the biotin-ELP concentration to 1 mM [ Fig. 4(C,F) ].
To confirm direct binding between biotin-ELPs and multiple sites on streptavidin, binding thermodynamics and stoichiometry were evaluated using ITC [ Fig. 3 ]. ITC is a powerful label-free technique to evaluate bio-molecular interactions using thermodynamic measurements. Calorimetry was performed below the ELP T t to determine the relationship between substrate binding in the soluble state. Saturable heat release was observed, which suggests specific interaction between biotin and streptavidin domain [ Fig. 3(A) ]. The sharp inflection in DH on successive injections of biotin-ELP occurred just before hitting saturation where the stoichiometry of biotin-ELP/streptavidin was 2.77 6 0.06 [ Fig. 3(B) ]. This confirms that our bacteria-derived source of streptavidin has a capacity to assemble trimeric complexes and rules unlikely the extensive formation of tetramers. A similar binding stoichiometry of 2.5 sites was reported previously where ITC was used to study interaction between free biotin and streptavidin 29 ; furthermore, that report used the same commercial source for streptavidin as used here. This suggests that fusion of 77 kDa ELP to biotin does not radically hinder its ability to bind to between 1 and 3 pockets on each streptavidin. Using the "one set of sites" binding model, the ITC binding curve was best fit by a K d of 5.4 6 3.2 nM [ Fig. 3(B) ]. Using other techniques, biotin affinities for M. This limitation occurs due to the steep increase in molar heat of injection with small increase in the biotin/streptavidin ratio. Hence, the best interpretation of this affinity is that each of the 3 binding pockets on streptavidin has an apparent affinity for biotin-ELP at or below 5.4 nM. A gain in binding enthalpy (DH) of 269.8 6 5.1 kJ/mol indicates that binding is an exothermic reaction with heat released due to noncovalent association between biotin-ELP and streptavidin favoring an enthalpy-driven binding mechanism. A positive (-TDS) value of 22.3 6 5.4 kJ/mol revealed an entropic cost due to loss in conformational ligand entropy associated with a decrease in the disordered state of biotin-ELP when bound to streptavidin. The sum of enthalpy and entropy, given by a negative Gibbs free binding energy (DG) of 247.5 6 1.4 kJ/mol suggests that biotin-ELP crosslinking around a streptavidin core remains a thermodynamically favorable interaction at relevant concentrations. Biotin-streptavidin thermodynamics have been studied previously by other groups using atomic force microscopy 32 and ITC, 29, 30 giving similar DH, -TDS and DG values to that observed in our hands. Small differences in these values could be attributed to difference in bacterial versus mammalian expressed streptavidin, fusion of 77 kDa ELP to biotin, and differences in buffers. 29 The relationship between ELP crosslinking and the change in T t with increasing streptavidin ratios suggests phase separation occurs in three different regimes [ Fig. 5 ]. First, in absence of streptavidin, biotin-ELPs remain unassociated and undergo phase separation at a particular T t . Second, with small increments in streptavidin concentration, a sharp downward shift in T t occurs due to the formation of ELP multimers. At low streptavidin concentrations, the biotin-ELP remains at great excess. As the concentration of streptavidin is increased, the complexation of two or three ELPs decreases the T t of the solution. This proceeds up to a point; however, when the target approaches its molar stoichiometric ratio [4:1] , the maximum concentration of biotin-ELP multimeric complexes is produced, yielding a maximal drop in T t . Third, at streptavidin concentrations above stoichiometry, the biotin-ELPs become saturated with excess streptavidin such that only 1:1 complexes are formed. Since the 1:1 complexes have a higher T t than the multimers, the T t of the system returns upward to a plateau [ Fig. 5(C) ]. This data confirms that biotin-ELPs are not only sensitive to streptavidin concentration, but that they respond differently to streptavidin below and above stoichiometry. This observation is consistent with particle size distributions obtained using light scattering [ Fig. 5(E) , Table II ]. At a biotin-ELP to streptavidin ratio below stoichiometry [16:1] , the R h of the crosslinked complex was larger than either free biotin-ELP or streptavidin. This suggests that biotin-ELP is sensitive to crosslinks by small amounts of streptavidin, which produces a drop in T t . When approaching the stoichiometric molar ratio of [4:1], a maximum particle size was observed, which is consistent with the greatest extent of multimers yielding the lowest T t . When biotin-ELPs and streptavidin were mixed in a ratio above stoichiometry [1:1] , the R h decreased again, which correlates with an increase in the T t [ Fig. 5(C) ]. Together this data consistently describes how multimeric complexation increases ELP density around a streptavidin core, which decreases T t , and leads to isothermal phase separation of these complexes.
ELPs are highly tunable protein-polymers that can be genetically designed to respond to target concentrations across physiological temperatures. This proof of concept study demonstrates how biotin-ELP was tuned to respond to streptavidin from 33.58C to 378C by decreasing the ELP concentration from 5 to 1 mM. To accomplish this, we introduced a new ELP called 2VA192, which was intentionally designed to phase separate in the physiological range of 30-408C at concentrations from 1 to 10 mM [ Fig. 2(B) ]. To modulate this detection range, ELPs with different lengths or guest residue compositions can be synthesized to respond to targets at different concentrations or temperatures. For instance, an ELP, V192 with only valine as guest residue (Xaa 5 Val, l 5 192 pentamers) might respond to streptavidin at 378C at concentrations lower than 1 mM since its transition temperature is lower than 2VA192. Alternatively, an ELP, A192 with only alanine as guest residue (Xaa 5 Ala, l 5 192 pentamers) might respond to streptavidin at 378C at concentrations greater than 1 mM since its transition temperature is higher than 2VA192. Furthermore, ELPs with different lengths having the same guest residue composition might also be designed to respond to targets at temperatures above or below 378C. Provided that both the relevant temperature and concentration of the target protein is known, it should be possible to detect other protein targets under isothermal conditions using this strategy.
Conclusion
Through noncovalent, reversible phase separation, ELPs both detect and respond to target microenvironments; however, their targets have been mostly limited to ionic species, pH, or heat. Since ELPs are also strongly responsive to molecular weight, there remains an untapped potential to engineer them to respond to more specific biomolecular cues, such as proteins. Building on our previous findings that ELPs can respond to a small dimeric ligand, this manuscript presents a rational strategy to engineer ELPs that detect a high molecular weight multimeric protein. Using streptavidin as a model protein, this manuscript describes how biotin-ELPs behave as "smart polymers" capable of phase separation upon detection of their target, even at fixed temperature. Based on this proof-of-concept study, it may become feasible to design ELPs into diagnostics and therapeutics that respond to multimeric macromolecules such as antibodies, cytokines, and tyrosine kinase receptors.
Materials and Methods
ELP expression, purification and characterization
A modified pET25b(1) vector containing the ELP 33 gene was transfected into BLR (DE3) E. coli competent cells (EMD Millipore, Billerica, MA) and inoculated onto Agar plates with 100 mg/mL ampicillin. A batch of 3-4 liters of bacterial culture was grown at 378C by overnight inoculation with bacterial cells obtained from a 50 mL terrific broth starter culture supplemented with 100 mg/mL carbenicillin. Cultures were harvested by centrifugation at 4000 rpm for 12 min at 378C and cells were resuspended in cold PBS (Dulbecco's sterile PBS buffer, PBL01, Caisson labs, Smithfield, UT). Resuspended cells were lysed using a microfluidizer (Microfluidics, Newton, MA) to release cytosolic ELPs. Polyethylene imine (0.5%) was added to the lysed cells for coprecipitation of DNA. Cells were then centrifuged at 4000 rpm for 12 min at 48C to remove insoluble cellular debris. ELP in the supernatant was purified using Inverse Transition Cycling. 34 Purification cycles were repeated 3-4 times until > 90% purity was achieved by SDS-PAGE. ELP was filtered using 200 nm cellulose acetate filters (28145-477, VWR, Radnor, PA) and concentration was estimated using Beer-Lambert's law at A 280 using 1285 M 21 cm 21 as the molar extinction coefficient. 35 Purity and identity was determined by loading 5 mg ELP in SDS loading buffer, heating at 958C for 5 min, and running on a 4-20% gradient Tris-Glycine SDS PAGE gel (58505, Lonza, Walkersville, MD). A standard Kaleidoscope protein ladder (161-0395, Bio-Rad, Hercules, CA) was run for comparison. Gels were stained using 10% w/v copper chloride and imaged using a VersaDoc (Bio-Rad, Hercules, CA) Gel Imager [ Fig. 2(A) ]. The purity was quantified using ImageJ (NIH, USA) using the following equation:
where A peak is the area of the protein band peak and A tot is the total area under all the peaks in the lane.
Biotin labeling and quantification of ELPs
Purified ELP, 2VA192, having a single primary amine at the amino terminus was conjugated with biotin using N-hydroxysuccinimide chemistry. Briefly, 200 mM ELP in PBS was mixed with 20 fold molar excess of Sulfo-NHS-biotin (21326, Thermo Fischer Scientific, Waltham, MA) dissolved in PBS. The reaction mixture was incubated on ice for 1 hour and then overnight at 48C. The reaction mixture was then dialyzed in PBS under 1:1000 sink condition to remove excess free biotin. The PBS buffer was replaced at 2 and 4 hour intervals and purified samples were collected after 16 hours. The biotin concentration was quantified using the HABA (4 0 -hydroxyazobenzene-2-carboxylic acid) quantification kit (28005, Thermo Fischer Scientific), and this value was used to estimate a biotin labeling of 88.9%.
Biotin-ELP kinetics and transition temperature determination
The ELP transition temperature, T t , was determined using a UV-Vis spectrophotometer over a temperature gradient. ELPs at different concentrations in PBS were heated from 20 to 508C in Beckman Coulter Tm microcells (Brea, CA). The temperature was increased at rate of 18C/min with readings taken every 0.38C. Optical density at 350 nm was collected, and the T t was defined as the lowest temperature where ELPs could be observed undergoing phase separation, taken as the OD measurement 5% above baseline [ Fig. 2(B) ]. Biotin-ELPs were mixed with [4:1] ratio of streptavidin (S4762, Sigma Aldrich Inc, St. Louis, MO) and T t was determined by performing temperature ramps [ Fig. 4(A,D) ]. Similarly, T t of biotin-ELPs mixed with streptavidin below and above stoichiometry was determined [ Fig. 5(A-C) ]. The kinetics of biotin-ELP coacervation at constant temperature was performed by measuring optical density over time after addition of streptavidin in [4:1] ratio [ Fig. 4(C,F) ].
Thermodynamics for streptavidin and biotin-ELP assembly
The equilibrium dissociation constant and thermodynamic parameters between biotin-ELP and streptavidin were studied using Isothermal Titration Calorimetry [ Fig. 3 ] on a MicroCal PEAQ ITC (Malvern Instruments, Worcestershire, United Kingdom). The reference cell was filled with water, and calorimetry was performed at 258C. Standard titrations were performed with streptavidin (300 ml at 1 mM in PBS) in the calorimeter cell and a titration syringe filled with biotin-ELP (30 mM in PBS) was injected (3 ml) into the calorimeter cell 12 times, allowing sufficient time between successive injections to facilitate equilibration. The resulting isotherm was fitted to a "one-set-of-sites" binding model in offset mode using MicroCal PEAQ ITC analysis software (Malvern Instruments) to generate affinity (K d ), number of binding sites, enthalpy (DH), entropy (-TDS), and the Gibbs free energy of binding (DG) . All values are reported as mean 6 SD (n 5 3).
Particle size measurement using dynamic light scattering
Purified biotin-ELPs were evaluated in the absence and presence of streptavidin for their hydrodynamic radius (R h ) using Dynamic Light Scattering at 258C on a Wyatt Dynapro plate reader (Santa Barbara, CA) [ Fig. 5(E) ]. High concentration solutions of biotin-ELP and streptavidin in PBS were filtered separately using 200 nm sterile AcrodiscV R 
Supporting Information
Genes encoding for the (2VA) ELP library with increasing chain length are shown in Supporting Information Table SI. Unmodified control ELP unable to detect and respond to streptavidin is shown in Supporting Information Figure S1 .
